The investigation has determined that discordant reactive vitros (b)(6)results were obtained from two different samples from a single patient using vitros immunodiagnostic products (b)(6) reagent lot 3310 in combination with a vitros 3600 immunodiagnostic system.The results were discordant when compared to (b)(6) results obtained from two different non-vitros methods.A definitive assignable cause for the discordant vitros results could not be determined with the information provided.Based on historical quality control (qc) results, a vitros (b)(6) reagent performance issue is not a likely contributor to the event as all qc fluid results were within expectations.In addition, continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros (b)(6) reagent lot 3310.Precision testing was not conducted on the vitros 3600 immunodiagnostic system therefore, an instrument related issue could not be entirely ruled out as a contributor to the event.However, there is no indication of an instrument malfunction.Additionally, pre-analytical sample processing cannot be ruled out as a contributing factor.The customer was not following the sample collection device manufacturer¿s recommended centrifugation protocol.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.Furthermore, the presence of an unknown sample interferent cannot be completely ruled out as the cause of the discordant reactive vitros results as no sample volume remained available to test using blocking tubes.
|